A Safety and Efficacy Study of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
Clinical trial NCT03567057 · COMPLETED
Trial details
- NCT number
- NCT03567057
- Sponsor
- Adamas Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-18
- Primary completion
- 2020-11-17
- Enrollment
- 424
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.